CD8A and neoplasm: Especially, DLAT could promote the growth of LIHC cells by targeting autophagy and lead to increased immune invasion of Tregs, thus inhibiting the responses of CD4+ and CD8+T cells and ultimately promoting the occurrence of LIHC by inhibiting anti-tumor immunity.